Paul Trippier is an associate professor in the College of Pharmacy and a member of the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center. Paul received a M.Chem. in Chemistry, Drug Design and Toxicology from the University of Hull in the United Kingdom and his D.Phil. from the University of Oxford under the supervision of Prof. Mark Moloney. He completed post-doctoral research in medicinal chemistry with Prof. Chris McGuigan at Cardiff University and in chemical biology with Prof. Rick Silverman at Northwestern University. Paul’s research group focuses on small molecule drug discovery and target identification for a number of indications including cancer, neurodegenerative diseases and stroke.